Literature DB >> 31102571

Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer.

Panu P Tonttila1, Anne Ahtikoski1, Mari Kuisma1, Eija Pääkkö1, Pasi Hirvikoski1, Markku H Vaarala1.   

Abstract

OBJECTIVES: To evaluate the diagnostic value of multiparametric prostate magnetic resonance imaging (mpMRI) prior to radical prostatectomy with curative intent for the detection of cribriform architecture (CA) and intraductal prostate cancer (IDC), which have recently been demonstrated to be adverse pathological features. PATIENTS AND METHODS: The study included 124 men who underwent mpMRI prior to radical prostatectomy at our centre. Preoperative mpMRI, prostatectomy histology and clinical follow-up details were reviewed retrospectively. The diagnostic value of mpMRI was evaluated on the basis of the detection rate. Secondly, the prognostic significance of CA/IDC among grade group (GG)2 cancers with regard to biochemical recurrence (BCR)-free survival was assessed using Kaplan-Meier analysis, with the log rank test and Fisher's exact test.
RESULTS: Pathological examination of radical prostatectomy specimens identified CA/IDC in 89 of 124 cases (71%) and mpMRI identified 86/95 of tumours including any CA/IDC with a sensitivity of 90.5% (95% confidence interval 82.8-95.6%). When localization of the lesions was compared, there was an association between the highest Prostate Imaging-Reporting and Data System classification and the highest pathological grade in 106 of the 124 cases (85.5%). In patients with GG2 lesions, BCR occurred in 11 of 31 (35.5%) with CA/IDC and two of 21 (9.5%) without CA/IDC (P = 0.034).
CONCLUSION: Multiparametric MRI has good sensitivity for detection of pathological primary prostate cancer, including most cases with CA/IDC; however, reliable prediction of GG2 tumours with CA/IDC for individual risk stratification remains challenging.
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #ProstateCancer; #pcsm; cribriform growth pattern; intraductal prostate cancer; multiparametric magnetic resonance imaging

Mesh:

Year:  2019        PMID: 31102571     DOI: 10.1111/bju.14812

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.

Authors:  Caterina Gaudiano; Lorenzo Bianchi; Antonio De Cinque; Beniamino Corcioni; Francesca Giunchi; Riccardo Schiavina; Michelangelo Fiorentino; Eugenio Brunocilla; Rita Golfieri
Journal:  Radiol Med       Date:  2021-11-30       Impact factor: 3.469

Review 2.  Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.

Authors:  Amanda B Hesterberg; Jennifer B Gordetsky; Paula J Hurley
Journal:  Urology       Date:  2021-05-28       Impact factor: 2.633

Review 3.  Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer.

Authors:  Niklas Harland; Arnulf Stenzl; Tilman Todenhöfer
Journal:  World J Mens Health       Date:  2020-06-24       Impact factor: 5.400

4.  Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.

Authors:  Joseph M Norris; Lina M Carmona Echeverria; Benjamin S Simpson; Rhys Ball; Alex Freeman; Daniel Kelly; Alex Kirkham; Hayley C Whitaker; Mark Emberton
Journal:  BMJ Open       Date:  2020-10-22       Impact factor: 2.692

Review 5.  Current Understanding and Management of Intraductal Carcinoma of the Prostate.

Authors:  Bryden Considine; Adebowale Adeniran; Michael E Hurwitz
Journal:  Curr Oncol Rep       Date:  2021-07-16       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.